7MCF
CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 2-{3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-6-fluoro-5-[(S)-(3-fluoropyridin-2-yl)(oxan-4-yl)methyl]-5H-pyrido[3,2-b]indol-7-yl}propan-2-ol
Summary for 7MCF
Entry DOI | 10.2210/pdb7mcf/pdb |
Descriptor | Bromodomain-containing protein 4, 2-{3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-6-fluoro-5-[(S)-(3-fluoropyridin-2-yl)(oxan-4-yl)methyl]-5H-pyrido[3,2-b]indol-7-yl}propan-2-ol (3 entities in total) |
Functional Keywords | bromodomain-containing protein 4 isoform long, brd4, bromodomain containing protein 4, cap, hunk1, mcap, mitotic chromosome associated protein sgc, cell cycle |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 31480.17 |
Authors | Sheriff, S. (deposition date: 2021-04-02, release date: 2021-05-26, Last modification date: 2023-10-18) |
Primary citation | Hill, M.D.,Fang, H.,Tokarski, J.,Fanslau, C.,Haarhoff, Z.,Huang, C.,Kramer, M.,Menard, K.,Monereau, L.,Morrison, J.,Ranasinghe, A.,Shields, E.E.,Tye, C.K.,Westhouse, R.,Everlof, G.,Sheriff, S.,Yan, C.,Marsilio, F.,Zhang, L.,Zvyaga, T.,Lee, F.,Gavai, A.V.,Degnan, A.P. Development of BET inhibitors as potential treatments for cancer: A search for structural diversity. Bioorg.Med.Chem.Lett., 44:128108-128108, 2021 Cited by PubMed: 33991625DOI: 10.1016/j.bmcl.2021.128108 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.19 Å) |
Structure validation
Download full validation report